Comparative effectiveness of delivering early palliative care via video versus in-person on end-of-life outcomes in patients with advanced lung cancer.

J Jessica R. Bauman (Fox Chase Cancer Center, Philadelphia, PA) A Areej El-Jawahri (1Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA) S Simone Rinaldi (Massachusetts General Hospital, Boston, MA) V Vicki Jackson (Massachusetts General Hospital, Boston, MA) E Emily R. Gallagher-Medeiros (Massachusetts General Hospital, Boston, MA) N Nora K. Horick (Mass General Brigham Cancer Institute, Boston, MA) D Dustin Rabideau (Massachusetts General Hospital, Boston, MA) J Jacob J. Strand (Mayo Clinic, Rochester, MN) F Finly Zachariah (City of Hope National Medical Center, Madras, OR) L Laura Kay Shoemaker (Cleveland Clinic, Cleveland, OH) M Marie Bakitas L Lori Ann Spoozak (University of Kansas Medical Center, Department of Internal Medicine, Kansas City, KS) C Carl Grey K Kimberly A. Curseen (Emory School of Medicine, Morrow, GA) E Eytan Szmuilowicz (Northwestern University Feinberg School of Medicine, Chicago, IL) R Ramona Rhodes (UT Southwestern Medical Center, Dallas, TX) A Amelia M. Cullinan (Dartmouth-Hitchcock Medical Center, Lebanon, NH) B Brianna Jewett (Massachusetts General Hospital, Boston, MA) J Jennifer S. Temel (Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital; Harvard Medical School, Boston, MA) J Joseph Greer (1Mass General Brigham, Department of Psychiatry, Boston, United States)

Abstract

1649 Background: Findings from our prior large-scale comparative effectiveness trial showed the equivalent effect of delivering early palliative care via video versus in-person on quality of life among patients with advanced non-small cell lung cancer (NSCLC). We now report on whether the two care delivery modalities were equivalent with respect to patient-reported communication with clinicians about their end-of-life (EOL) care preferences and hospice utilization. Methods: Between 6/14/2018 and 5/4/2023, we enrolled 1250 patients with newly diagnosed advanced NSCLC in a randomized trial of early palliative care across 22 US cancer centers. Patients were randomly assigned to meet with a palliative care clinician every 4 weeks from enrollment through the course of the disease, either via video or in the outpatient clinic. Participants completed self-report surveys at baseline and weeks 12, 24, 36, and 48, including an item asking if they had discussed with their clinicians the care they would want to receive if dying (yes/no); patients’ final assessments prior to death or last follow up were analyzed. We reviewed patients’ health records to collect data on hospice referral and length of stay. To test the equivalence in these outcomes, we used a binomial generalized linear model with the identity link function (pre-specified equivalence margin of ±8% for patient-reported communication about EOL care) and linear regression (pre-specified equivalence margin of ±6 days for mean length of stay in hospice). P-values were adjusted for multiplicity using a Bonferroni correction. Results: Of the 1250 enrolled participants, 888 (71.0%) completed at least one survey post baseline regarding whether they communicated with clinicians about EOL care preferences. Among those, 29.1% of the video group and 26.0% of the in-person group reported “yes,” indicating that they recalled such EOL care discussions (difference = 3.1%, 95% CI: -1.8%, 8.1%; p = 0.26 for equivalence). During the course of the trial, 733/1250 (58.6%) patients died, of whom 537/733 (73.3%) were referred to hospice. Mean lengths of hospice stay were 25.3 days for the video group versus 25.1 days for the in-person group (difference = 0.2, 95% CI: -7.0, 7.4; p = 0.46 for equivalence). When excluding outlying patients receiving hospice services > 180 days (n = 13), the mean lengths of hospice stay were 19.1 (video group) versus 19.7 (in-person group) days (difference = -0.6, 95% CI: -4.6, 3.3; p = 0.06 for equivalence). Conclusions: Although thresholds were not met to confirm equivalence statistically, the two modalities for delivering early palliative care demonstrate very similar outcomes with respect to patient-clinician communication about EOL care and hospice utilization. These findings provide further evidence of the utility of video visits for providing high quality palliative and EOL care. Clinical trial information: ClinicalTrials.gov Identifier ( NCT03375489 ) .

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
Pages 1649-1649
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (20)

J

Jessica R. Bauman

Fox Chase Cancer Center, Philadelphia, PA

A

Areej El-Jawahri

1Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA

S

Simone Rinaldi

Massachusetts General Hospital, Boston, MA

V

Vicki Jackson

Massachusetts General Hospital, Boston, MA

E

Emily R. Gallagher-Medeiros

Massachusetts General Hospital, Boston, MA

N

Nora K. Horick

Mass General Brigham Cancer Institute, Boston, MA

D

Dustin Rabideau

Massachusetts General Hospital, Boston, MA

J

Jacob J. Strand

Mayo Clinic, Rochester, MN

F

Finly Zachariah

City of Hope National Medical Center, Madras, OR

L

Laura Kay Shoemaker

Cleveland Clinic, Cleveland, OH

M

Marie Bakitas

L

Lori Ann Spoozak

University of Kansas Medical Center, Department of Internal Medicine, Kansas City, KS

C

Carl Grey

K

Kimberly A. Curseen

Emory School of Medicine, Morrow, GA

E

Eytan Szmuilowicz

Northwestern University Feinberg School of Medicine, Chicago, IL

R

Ramona Rhodes

UT Southwestern Medical Center, Dallas, TX

A

Amelia M. Cullinan

Dartmouth-Hitchcock Medical Center, Lebanon, NH

B

Brianna Jewett

Massachusetts General Hospital, Boston, MA

J

Jennifer S. Temel

Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital; Harvard Medical School, Boston, MA

J

Joseph Greer

1Mass General Brigham, Department of Psychiatry, Boston, United States